Liis Haljasmägi

5.9k total citations · 1 hit paper
13 papers, 601 citations indexed

About

Liis Haljasmägi is a scholar working on Infectious Diseases, Immunology and Rheumatology. According to data from OpenAlex, Liis Haljasmägi has authored 13 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Immunology and 3 papers in Rheumatology. Recurrent topics in Liis Haljasmägi's work include SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (4 papers) and T-cell and B-cell Immunology (4 papers). Liis Haljasmägi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (4 papers) and T-cell and B-cell Immunology (4 papers). Liis Haljasmägi collaborates with scholars based in Estonia, United Kingdom and France. Liis Haljasmägi's co-authors include Pärt Peterson, Kai Kisand, Pauliina Rumm, Liina Tserel, Epp Sepp, Paul Naaber, Jaanika Kärner, Anu Planken, Mart Ustav and Kadri Kangro and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and Scientific Reports.

In The Last Decade

Liis Haljasmägi

13 papers receiving 596 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study

2021 379 citations Paul Naaber, Liina Tserel et al. The Lancet Regional Health - Europe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liis Haljasmägi Estonia	8	470	120	96	79	74	13	601
Pauliina Rumm Estonia	5	446 0.9×	91 0.8×	93 1.0×	62 0.8×	73 1.0×	7	528
Philipp Niklas Ostermann Germany	8	350 0.7×	44 0.4×	67 0.7×	64 0.8×	58 0.8×	16	443
Nils Methot United States	3	457 1.0×	145 1.2×	47 0.5×	148 1.9×	40 0.5×	3	542
Qingqing Lin China	4	490 1.0×	92 0.8×	30 0.3×	91 1.2×	40 0.5×	11	584
William Bermingham United Kingdom	8	539 1.1×	63 0.5×	40 0.4×	56 0.7×	36 0.5×	12	628
Wiebke Moskorz Germany	4	297 0.6×	48 0.4×	65 0.7×	34 0.4×	51 0.7×	6	357
Johannes Ptok Germany	8	297 0.6×	37 0.3×	65 0.7×	121 1.5×	52 0.7×	16	452
Lara Walotka Germany	5	303 0.6×	39 0.3×	65 0.7×	74 0.9×	51 0.7×	8	388
Lena Hansen Norway	6	286 0.6×	109 0.9×	37 0.4×	87 1.1×	24 0.3×	11	464
Jean‐Louis Bayart Belgium	9	313 0.7×	47 0.4×	63 0.7×	38 0.5×	50 0.7×	22	410

Countries citing papers authored by Liis Haljasmägi

Since Specialization

Citations

This map shows the geographic impact of Liis Haljasmägi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liis Haljasmägi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liis Haljasmägi more than expected).

Fields of papers citing papers by Liis Haljasmägi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liis Haljasmägi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liis Haljasmägi. The network helps show where Liis Haljasmägi may publish in the future.

Co-authorship network of co-authors of Liis Haljasmägi

This figure shows the co-authorship network connecting the top 25 collaborators of Liis Haljasmägi. A scholar is included among the top collaborators of Liis Haljasmägi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liis Haljasmägi. Liis Haljasmägi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Bichele, Rudolf, Uku Haljasorg, Liis Haljasmägi, et al.. (2025). Impaired Aire-dependent IFN signaling in the thymus precedes the protective autoantibodies to IFNα. The Journal of Experimental Medicine. 222(7). 2 indexed citations

Haljasmägi, Liis, Madhvi Menon, Thomas McDonnell, et al.. (2023). Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets. Cell Reports Medicine. 4(1). 100894–100894. 26 indexed citations

Kisand, Kai, et al.. (2023). AB0692 SERUM INTERFERON Α (IFNΑ) LEVELS AND SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) DISEASE ACTIVITY IN SLE PATIENTS IN ESTONIA. A PROSPECTIVE COHORT STUDY OF 40 SLE PATIENTS IN ESTONIA. Annals of the Rheumatic Diseases. 82. 1549–1550. 1 indexed citations

Naaber, Paul, Liina Tserel, Kadri Kangro, et al.. (2022). Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine. Cell Reports Medicine. 3(8). 100716–100716. 15 indexed citations

Naaber, Paul, Liina Tserel, Kadri Kangro, et al.. (2021). Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. The Lancet Regional Health - Europe. 10. 100208–100208. 379 indexed citations breakdown →

Soeorg, Hiie, Freddy Lättekivi, Paul Naaber, et al.. (2021). Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study). Vaccine. 39(38). 5376–5384. 7 indexed citations

Berger, Sylvie, Agnès Chomel, Kai Kisand, et al.. (2021). S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases. Journal of Translational Autoimmunity. 4. 100093–100093. 2 indexed citations

Naaber, Paul, Liina Tserel, Kadri Kangro, et al.. (2021). Declined Antibody Responses to COVID-19 mRNA Vaccine within First Three Months. SSRN Electronic Journal. 2 indexed citations

Saare, Mario, Liina Tserel, Liis Haljasmägi, et al.. (2020). Monocytes present age‐related changes in phospholipid concentration and decreased energy metabolism. Aging Cell. 19(4). e13127–e13127. 43 indexed citations

10.

Haljasmägi, Liis, Pauliina Rumm, Anu Remm, et al.. (2020). Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19. Scientific Reports. 10(1). 20533–20533. 59 indexed citations

11.

Haljasmägi, Liis, Anu Remm, Pauliina Rumm, et al.. (2020). LIPS method for the detection of SARS‐CoV‐2 antibodies to spike and nucleocapsid proteins. European Journal of Immunology. 50(8). 1234–1236. 24 indexed citations

12.

Rühlemann, Malte, Jaanika Kärner, Liis Haljasmägi, et al.. (2020). IL-22 Paucity in APECED Is Associated With Mucosal and Microbial Alterations in Oral Cavity. Frontiers in Immunology. 11. 838–838. 15 indexed citations

13.

Naaber, Paul, Liis Haljasmägi, Pauliina Rumm, et al.. (2020). Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data. PLoS ONE. 15(10). e0237548–e0237548. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact